Juniper, Therapeutics Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore Published on 08/07/2025 at 18:00 | prnewswire.co.uk Juniper Biologics Singapore Hong Kong View original content:https://www.prnewswire.co.uk/news-releases/juniper-therapeutics-acquires-exclusive-rights-for-sar-registration-for-anti-viral-covid-19-drug-from-ping-an-shionogi-hong-kong-for-singapore-302021003.html en | boerse | 68017982 |
